RBP1 Inhibitors
RBP1, also known as Retinoblastoma Binding Protein 1, plays a crucial role in regulating cell cycle progression, DNA replication, and gene transcription by interacting with various cellular factors and transcriptional regulators. As a key component of the Rb-E2F transcriptional regulatory pathway, RBP1 functions to inhibit the activity of E2F transcription factors, thereby controlling the expression of genes involved in cell proliferation and differentiation. Additionally, RBP1 is implicated in chromatin remodeling and epigenetic regulation, contributing to the maintenance of genomic stability and cellular homeostasis.
Inhibition of RBP1 involves targeting its transcriptional regulatory functions and disrupting its interactions with key cellular factors involved in gene expression. Direct inhibitors of RBP1 include compounds that interfere with transcriptional processes by targeting RNA polymerase II or DNA-binding proteins, leading to the down-regulation of RBP1 expression. Additionally, compounds that induce DNA damage or inhibit DNA synthesis can indirectly suppress RBP1 by activating cellular stress response pathways. These mechanisms collectively contribute to the inhibition of RBP1 and offer potential strategies for modulating cellular proliferation and gene expression in various physiological and pathological contexts.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D binds to DNA, preventing transcription initiation and leading to the inhibition of RBP1 expression. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
α-Amanitin inhibits RNA polymerase II, hindering transcriptional elongation and consequently suppressing RBP1 mRNA synthesis. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $90.00 $204.00 | 13 | |
Triptolide inhibits transcription by targeting XPB, a subunit of TFIIH complex, leading to reduced RBP1 expression through transcriptional inhibition. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
Camptothecin inhibits topoisomerase I, resulting in DNA damage and the activation of DNA damage response pathways, ultimately suppressing RBP1. | ||||||
Flavopiridol | 146426-40-6 | sc-202157 sc-202157A | 5 mg 25 mg | $78.00 $259.00 | 41 | |
Flavopiridol inhibits CDKs, including CDK9, thereby blocking RNA polymerase II-mediated transcription and down-regulating RBP1 expression. | ||||||
Ellipticine | 519-23-3 | sc-200878 sc-200878A | 10 mg 50 mg | $145.00 $569.00 | 4 | |
Ellipticine intercalates into DNA, leading to the inhibition of DNA synthesis and transcription, consequently suppressing RBP1 expression. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $37.00 $152.00 | 11 | |
Fluorouracil inhibits thymidylate synthase, disrupting nucleotide synthesis and leading to the down-regulation of RBP1 expression. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
Mithramycin A binds to GC-rich DNA sequences, interfering with transcriptional regulation and suppressing RBP1 expression. | ||||||